Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.7B
154M shares
52-week range
$6.82 – $23.29
24% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
P/S (TTM)
2.0
EV / FCF (TTM)
518
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
www.atecspine.comNo one on the platform currently holds ATEC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,055,100 | $11.5M |
| Execution date | Ratio |
|---|---|
| 2016-08-25 | 1-for-12reverse |
No one on the platform has traded ATEC yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| Rev. Growth % | 25.0% | 39.5% | ||||
| Profit Margin % | -18.8% | -37.2% | -35.0% | |||
| Free Cash Flow Margin % | 0.4% | -30.6% | -30.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +30.8% on the P/E track.
At today's price, your expected annual return is +37.3% on the P/E track.
At today's price, your expected annual return is +42.7% on the P/E track.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Stocks to Watch Tomorrow (Sept 14, 2026): $ACVA Closed at $10.41, Up 44.18% on a $1.9B Buyout $SMR Closed at $8.61, Down 15.67% on a UBS Sell Call $ATEC Closed at $10.58, Up 19.68% on a $1 Million CEO Bet $FEIM Closed at $88.38, Up 42.40% on Record Earnings $PMTS Closed at $22.50, Down 16.48% on a Secondary Offering https://truthsandnews.com/markets/stocks-to-watch-tomorrow-sept-14-2026-names-in-play
View on StockTwits ↗My Day Trading Watch List Video for September 14th in About 2 Minutes (con't): $SUNE $ATEC $TTAN $SST $RCUS .
View on StockTwits ↗
$ATEC seeing some interesting options flows here. CEO buy last night through a form 4.
View on StockTwits ↗
$ATEC CEO purchased 115,000 shares at $8.81 for a total of $1,013,150. Miles Patrick now owns 6,154,451 shares. https://ceo-buys.com
View on StockTwits ↗$ATEC just wait for Dec this things is gonna have some solid wings then!
View on StockTwits ↗
$HRTX 90K shares @ $2.2 Man, I bought this stock at $20 years ago. I really thought they could climb back to $7 SP even after all the fumbles. I’d be happy with any type of sale at this point. $ATEC is saving me from this poo water of dead money
View on StockTwits ↗
$ATEC wayyyyyy too cheap for the growth… only 2x fwd EV/sales vs peers at 3-4x despite having more than double the growth. Things worth $15-20 easy. 🦾💵 $XLV $IWM $IHI $XBI
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $882M | +15.6% | $0.33 | $0.32–$0.33 | 32.9× | 6 |
| 2027 | $1.0B | +15.1% | $0.61 | $0.58–$0.63 | 17.6× | 7 |
| 2028 | $1.2B | +14.2% | $0.88 | $0.87–$0.90 | 12.2× | 6 |
| 2029 | $1.3B | +12.7% | $1.03 | $1.01–$1.05 | 10.4× | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $0.07 | $0.07 | +0.8% |
| 2026-05-05 | $-0.01 | $-0.22 | -2100.0% |
| 2026-02-24 | $0.04 | $0.06 | +50.0% |
| 2025-10-30 | $-0.03 | $0.03 | +200.0% |
| 2025-07-31 | $-0.06 | $0.02 | +133.3% |
| 2025-05-01 | $-0.12 | $-0.23 | -91.7% |
| 2025-02-26 | $-0.19 | $-0.23 | -21.1% |
| 2024-10-30 | $-0.25 |
| $-0.28 |
| -12.0% |
| -0.94% |
| $3.6B |
| — |
| IRONDisc Medicine, Inc. | $67.64 | -1.86% | $2.6B | — |
| LEGNLegend Biotech Corporation | $18.00 | -2.83% | $3.3B | — |
Source: Financial Modeling Prep · peers by sector/industry